Filing Details

Accession Number:
0001214659-23-016923
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-27 16:30:16
Reporting Period:
2023-12-22
Accepted Time:
2023-12-27 16:30:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1677077 Alzamend Neuro Inc. ALZN () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1212502 Iii C Milton Ault 11411 Southern Highlands Parkway
Suite 240
Las Vegas NV 89141
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-22 200 $0.92 166,866 No 4 P Direct
Common Stock Acquisiton 2023-12-26 500 $0.90 26,032 No 4 P Indirect By Ault Alpha LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Indirect By Ault Alpha LP
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 737,333 Indirect By Ault Lending, LLC
Common Stock 996,198 Indirect By Ault Life Sciences, Inc.
Common Stock 666,666 Indirect By Ault Life Sciences Fund, LLC
Footnotes
  1. Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP.
  2. Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
  3. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
  4. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.